Rudra Investment Stock Market Expert report says In the business of Monday, the pharmaceutical company Shilpa Medicare has been good. During the business, shares rose by 13 percent to 515 rupees. The company has issued the Establishment Inspection Report (EIR) on behalf of the USFDO, after which the stock has risen.

EIR has been issued for Telangana unit

Shilpa Medicare has informed the stock exchanges that the company has issued EIR for the Jardcherla unit in Telangana by the USFDA. The USFDA surveyed the plant between November 11 and November 30 last year. This plant has a formulation manufacturing facility. After the survey, USFDA has decided to issue EIR to the company.

Move on such a stock

Shilpaamdicare’s stock closed at a price of Rs 455 on Friday. At the same time, open on Monday’s business at a price of 467 rupees. During the trading, it rose by 13 percent to Rs 515. In today’s business, the share price has been worth only Rs 467. At present, the stock is trading at more than 8 percent and is trading at Rs 492. In the past one year, the stock has fallen nearly 42% in the stock till Friday. The stock had come at a price of Rs 646 to Rs 455.

Better numbers in the third quarter

Shilpa Medicare had a profit of Rs 18.41 crore in the third quarter of the financial year. In the third quarter of last financial year, the company had a profit of Rs 15.63 crore. Meanwhile, Net Sales of the company has increased from Rs 187.60 crores to Rs 190.59 crores during this period.

Get Free Trial Visit Here:- http://rudrainvestment.com/free_trail.php